Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars
NCT ID: NCT05585112
Last Updated: 2023-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
26 participants
INTERVENTIONAL
2022-10-17
2022-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children, aged 6-12years old
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Local Anesthesia With Lidocaine or Articaine for Molars Affected by MIH
NCT05200884
Efficacy of Differents Anaesthetics in Mandibular Third Molar Germectomy
NCT04465149
Articaine 4% Efficacy and Safety in Extraction and Pulpotomy of Primary Molars of Children Below the Age of Four Years
NCT05101785
The Anesthetic Efficacy of Lidocaine and Articaine as Buccal Injection for Maxillary Premolar Teeth Extraction.
NCT05951907
Efficiency of Single Buccal Infiltration Versus Buccal and Intrapapillary Infiltration
NCT04458142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are no studies comparing the effectiveness of lidocaine and articaine in MIH-maxillary molars.
Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children , aged 6-12 years old. Each child was randomly assigned to either articaine 4% or lidocaine 2% in their first session with the second solution being used at the second session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A (Lidocaine 2%)
26 children will be injected with 1 ml of lidocaine 2% with epinephrine
Lidocaine 2%
The child will be injected with lidocaine 2%,after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and pain after injection and treatment will be evaluated using the Wong-Baker faces pain rating scale
B (Articaine 4%)
26 children will be injected with 1 ml of Articaine 4% with epinephrine.
Articaine 4%
The child will be injected with 4% Articaine, after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and Wong-Baker faces pain rating scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine 2%
The child will be injected with lidocaine 2%,after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and pain after injection and treatment will be evaluated using the Wong-Baker faces pain rating scale
Articaine 4%
The child will be injected with 4% Articaine, after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and Wong-Baker faces pain rating scale
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* child is not under the effect of any analgesics or sedatives and their weight was more than 20 kg.
* Healthy, both physically and mentally
* A child with a MIH-affected maxillary permanent first molar on the right and left sides .
Exclusion Criteria
* allergic anesthetics used in the study
* children who show inflammation in the injection site.
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tishreen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nabih Raslan, Dr
Role: STUDY_CHAIR
Tishreen University
Mai Haidar, Dr
Role: PRINCIPAL_INVESTIGATOR
Tishreen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tishreen University
Latakia, , Syria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tishreen U _Local anesthesia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.